Clinical Trial Update: Recombinant Human Growth Hormone (rHGH) for Knee Osteoarthritis (KORR) [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial is currently recruiting to evaluate recombinant human growth hormone for knee osteoarthritis (KORR).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis of the Knee

Drugs mentioned

• Recombinant human growth hormone (somatropin)

Snippet

Sponsor: Dr. David Wasserstein | Conditions: Knee Osteoarthritis (Knee OA), Knee Osteoarthritis (OA) | Phase 1, Phase 2 | Status: RECRUITING